Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Stimulator, electrical, implantable, for incontinence

Número de PMA: P970004 · 2026-09-14

SolicitanteMedtronic Neuromodulation
Fecha de decisión2026-09-14
Número PMAP970004
Código de productoEZW
Clase del dispositivoClase 3
Especialidad médicaG
Número de regulación21 CFR 8
Comité asesorGU

Resumen del dispositivo

Stimulator, electrical, implantable, for incontinence is the device name listed in this FDA 510(k) record. The listed applicant is Medtronic Neuromodulation. It received FDA 510(k) clearance on 2026-09-14. The device is classified under product code EZW. It was reviewed by the GU advisory panel.

Preguntas frecuentes

What is the Stimulator, electrical, implantable, for incontinence?

Stimulator, electrical, implantable, for incontinence is a medical device that received FDA 510(k) clearance on 2026-09-14. The listed applicant is Medtronic Neuromodulation.

When did Stimulator, electrical, implantable, for incontinence receive FDA 510(k) clearance?

The clearance date for Stimulator, electrical, implantable, for incontinence can be found in the official FDA records.

Who is the listed applicant for Stimulator, electrical, implantable, for incontinence?

The FDA 510(k) record lists Medtronic Neuromodulation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Stimulator, electrical, implantable, for incontinence?

The FDA product code for Stimulator, electrical, implantable, for incontinence is EZW.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑